RoboForce vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

RoboForce

EmergingRobotics

Industrial Labor Robots

Raised $52M for AI robots in dangerous industrial jobs. NVIDIA partnership. Jerry Yang backed (March 2026).

About

RoboForce is an industrial robotics company deploying AI-powered robots to perform dangerous, physically demanding jobs in industrial environments. The company was founded on the premise that a significant portion of the most hazardous industrial labor — work that causes high rates of injury and is increasingly hard to staff — can be automated with purpose-built robotic systems guided by advanced AI. RoboForce targets sectors including oil and gas, mining, construction, and heavy manufacturing, where conditions are too variable and unstructured for traditional industrial automation.\n\nThe company's robots combine mobility, dexterity, and AI perception to operate in real industrial worksites that are not designed for robots. Unlike warehouse automation or assembly line robots that work in controlled settings, RoboForce machines must navigate dynamic, hazardous environments — confined spaces, elevated structures, contaminated areas — making the AI decision-making layer as important as the physical hardware. The platform is designed to deploy alongside existing human workforces, taking over the specific tasks that pose the highest risk of injury or fatality.\n\nRoboForce raised $52M in March 2026, with investors including NVIDIA and backing from Jerry Yang, the co-founder of Yahoo. NVIDIA's participation reflects the deep compute requirements for real-time environmental perception and decision-making in unstructured industrial settings. With growing labor shortages in dangerous industrial jobs and increasing regulatory pressure on workplace safety, RoboForce is positioned to capture a large and underpenetrated market that traditional robotics vendors have not addressed.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.